trans-8-((4-Aminocyclohexyl)amino)-5-bromo-N-(furan-2-ylmethyl)-1,6-naphthyridine-7-carboxamide

ID: ALA2180570

PubChem CID: 45376706

Max Phase: Preclinical

Molecular Formula: C20H22BrN5O2

Molecular Weight: 444.33

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  N[C@H]1CC[C@H](Nc2c(C(=O)NCc3ccco3)nc(Br)c3cccnc23)CC1

Standard InChI:  InChI=1S/C20H22BrN5O2/c21-19-15-4-1-9-23-16(15)17(25-13-7-5-12(22)6-8-13)18(26-19)20(27)24-11-14-3-2-10-28-14/h1-4,9-10,12-13,25H,5-8,11,22H2,(H,24,27)/t12-,13-

Standard InChI Key:  PHCAOEZTFVJPSK-JOCQHMNTSA-N

Molfile:  

     RDKit          2D

 28 31  0  0  0  0  0  0  0  0999 V2000
   22.9180  -17.4518    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.6305  -17.8634    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.3417  -17.4495    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   25.0542  -17.8611    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.7653  -17.4473    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.0554  -18.6825    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   26.4724  -17.8603    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.4648  -16.2176    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.7612  -16.6290    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   27.1823  -16.6249    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.1794  -17.4440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.8867  -17.8563    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   28.5974  -17.4465    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.5963  -16.6243    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.8884  -16.2199    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.4607  -15.3963    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
   26.4749  -18.6816    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   27.1838  -19.0880    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.1823  -19.9021    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.8871  -20.3085    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.5960  -19.9012    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.5955  -19.0830    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.8861  -18.6722    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.3034  -20.3103    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   22.8306  -16.6377    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   22.0258  -16.4664    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.6142  -17.1789    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.1647  -17.7904    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  4  6  2  0
  5  7  2  0
  7 11  1  0
 10  8  1  0
  8  9  2  0
  9  5  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 10  2  0
  8 16  1  0
  7 17  1  0
 18 17  1  1
 18 19  1  0
 18 23  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 21 24  1  6
  1 25  1  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28  1  2  0
M  END

Associated Targets(Human)

HEY (175 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SK-BR-3 (5175 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-116 (91556 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDA-MB-435 (38290 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 444.33Molecular Weight (Monoisotopic): 443.0957AlogP: 3.60#Rotatable Bonds: 5
Polar Surface Area: 106.07Molecular Species: BASEHBA: 6HBD: 3
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 4#RO5 Violations (Lipinski):
CX Acidic pKa: 12.16CX Basic pKa: 10.44CX LogP: 2.43CX LogD: -0.18
Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.52Np Likeness Score: -1.32

References

1. Zeng LF, Wang Y, Kazemi R, Xu S, Xu ZL, Sanchez TW, Yang LM, Debnath B, Odde S, Xie H, Zheng YT, Ding J, Neamati N, Long YQ..  (2012)  Repositioning HIV-1 integrase inhibitors for cancer therapeutics: 1,6-naphthyridine-7-carboxamide as a promising scaffold with drug-like properties.,  55  (22): [PMID:23098137] [10.1021/jm300667v]

Source